Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Techdow Pharma USA is the United States subsidiary of Shenzhen Techdow Pharmaceutical, which is part of the Shenzhen Hepalink Pharmaceutical Group. The company specializes in the commercialization of injectable anticoagulant therapies, leveraging a vertically integrated supply chain from its parent company. Its primary product is Enoxaparin Sodium Injection, a generic version of Lovenox, which is used for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism. Techdow is recognized as one of the largest global suppliers of heparin-based products, maintaining rigorous quality standards and GMP-compliant manufacturing facilities. The US division focuses on expanding access to essential medicines within the hospital, retail, and clinical sectors. By controlling the process from raw material to finished dosage form, the company ensures a stable supply of critical cardiovascular medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Techdow Pharma USA.